Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Columbus NCORP RFA-CA-18-016

Award Number: UG1CA189954
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2014
PERIOD OF PERFORMANCE END DATE: 07/31/2026

Group Awards By:

View Award Description

Columbus NCORP RFA-CA-18-016 - Since its founding in 1983, the Columbus CCOP, now known as the Columbus NCORP, has been dedicated to providing high quality cancer care options in Central and Southeast Ohio as well as advancing cancer research through cancer research trials. The Columbus NCORP has grown in that time to encompass 20 affiliates and sub-affiliates, with 100 doctors serving as investigators. Over the six years comprising the next grant period, the NCORP plans to continue to grow in that capacity, improving its ability to participate in, assist with the design of, and successfully implement a wide range of cancer research trials, including treatment, cancer control, screening/surveillance, side effect prevention/management, and cancer care delivery research studies. In all areas the NCORP has been successful and plans to continue to grow in its ability to increase participation in cancer research in rural communities and Appalachia. Cancer care delivery research has been and continues to be a key component of this goal, as is continuing to improve care practices throughout the consortium. Close collaboration between NCORP affiliate institutions, non-oncology specialists, primary care physicians and community organizations is key to this goal. The Columbus NCORP plans to continue to pursue the cutting edge of cancer research through targeted and genomic therapies, while simultaneously seeking out and implementing trials that are directly applicable to those cancers with the highest incidence rate in our region: breast, colon and lung cancers. Over the past five years as an NCORP, and over the preceding 30 years as the Columbus CCOP, these areas have been a high priority and will continue to be as we aggressively pursue treatments that will advance the science of cancer care and best serve our local communities. The unique challenges facing Central and Southeast Ohio in these areas position the Columbus NCORP to make real and lasting contributions to cancer research, and the lessons learned here are widely applicable to regions across the country.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	000	11	1/29/2026	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $230,836 )
2025	2025	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	002	11	8/22/2025	SUPPLEMENT FOR EXPANSION	$230,836
2025	2024	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	000	11	7/24/2025	NON-COMPETING CONTINUATION	$0
2025	2024	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	001	11	8/18/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $230,836

Issue Date FY: 2024 ( Subtotal = $1,057,540 )
2024	2024	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	001	11	7/29/2024	NON-COMPETING CONTINUATION	$1,057,540
2024	2023	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	000	10	6/18/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,057,540

Issue Date FY: 2023 ( Subtotal = $1,291,768 )
2023	2023	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	001	10	8/18/2023	NON-COMPETING CONTINUATION	$1,315,168
2023	2018	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	5	3/22/2023	NON-COMPETING CONTINUATION	-$23,400
														Subtotal = $1,291,768

Issue Date FY: 2022 ( Subtotal = $344,347 )
2022	2022	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	001	9	7/28/2022	NON-COMPETING CONTINUATION	$344,347
2022	2021	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	000	8	4/27/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $344,347

Issue Date FY: 2021 ( Subtotal = $823,797 )
2021	2021	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	000	8	8/1/2021	NON-COMPETING CONTINUATION	$823,797
														Subtotal = $823,797

Issue Date FY: 2020 ( Subtotal = $825,770 )
2020	2020	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	002	7	8/4/2020	NON-COMPETING CONTINUATION	$825,770
2020	2019	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	001	6	3/25/2020	COMPETING CONTINUATION	$357,783
2020	2018	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	5	3/25/2020	NON-COMPETING CONTINUATION	-$357,783
														Subtotal = $825,770

Issue Date FY: 2019 ( Subtotal = $745,063 )
2019	2019	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	000	6	8/9/2019	COMPETING CONTINUATION	$745,063
2019	2019	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Control	001	6	8/16/2019	COMPETING CONTINUATION	$0
														Subtotal = $745,063

Issue Date FY: 2018 ( Subtotal = $664,603 )
2018	2018	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	5	7/31/2018	NON-COMPETING CONTINUATION	$664,603
														Subtotal = $664,603

Issue Date FY: 2017 ( Subtotal = $1,005,000 )
2017	2017	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN RD STE 124A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	4	8/1/2017	NON-COMPETING CONTINUATION	$1,005,000
														Subtotal = $1,005,000

Issue Date FY: 2016 ( Subtotal = $410,800 )
2016	2016	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN ROAD SUITE 124 A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	3	8/3/2016	NON-COMPETING CONTINUATION	$410,800
														Subtotal = $410,800

Issue Date FY: 2015 ( Subtotal = $942,500 )
2015	2015	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN ROAD SUITE 124 A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	2	7/31/2015	NON-COMPETING CONTINUATION	$942,500
														Subtotal = $942,500

Issue Date FY: 2014 ( Subtotal = $1,017,500 )
2014	2014	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN ROAD SUITE 124 A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	000	1	7/31/2014	NEW	$942,500
2014	2014	COLUMBUS COMMUNITY CLINICAL ONCOLOGY PROGRAM	1335 DUBLIN ROAD SUITE 124 A	COLUMBUS	OH	43215	FRANKLIN	USA	Cancer Treatment Research	001	1	9/16/2014	NEW	$75,000
														Subtotal = $1,017,500

Grand Total All Awards = $9,359,524

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Columbus NCORP RFA-CA-18-016

Award Number: UG1CA189954

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2014

PERIOD OF PERFORMANCE END DATE: 07/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer